StockDriftsStockDriftsTop 17 Foresite Capital Management VI LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 32.67% | 2.22M | $150.3M | +0.00%(+0) | $33.20(+111.90%) | 2026-03-31 | |
| ALMS | ALUMIS INC. | 20.33% | 4.25M | $93.6M | +0.00%(+0) | $9.22(+187.49%) | 2026-03-31 | |
| CNTA | Centessa Pharmaceuticals plc | 11.77% | 1.36M | $54.2M | +0.00%(+0) | $16.78(+141.41%) | 2026-03-31 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 5.82% | 1.83M | $26.8M | +32.58%(+450.00K) | $6.65(+129.15%) | 2026-03-31 | |
| DNLI | Denali Therapeutics Inc. | 5.05% | 1.21M | $23.2M | +21.00%(+209.97K) | $14.88(+73.59%) | 2026-03-31 | |
| AGIO | AGIOS PHARMACEUTICALS, INC. | 3.86% | 525.0K | $17.8M | -0.94%(-5.00K) | $33.68(+11.58%) | 2026-03-31 | |
| VSTM | Verastem, Inc. | 3.62% | 3.15M | $16.7M | +0.37%(+11.51K) | $6.25(-27.99%) | 2026-03-31 | |
| KYMR | Kymera Therapeutics, Inc. | 2.65% | 146.3K | $12.2M | +0.00%(+0) | $43.78(+159.27%) | 2026-03-31 | |
| NERV | Minerva Neurosciences, Inc. | 2.6% | 1.99M | $12.0M | new | $5.02(+1.54%) | 2026-03-31 | |
| CLDX | Celldex Therapeutics, Inc. | 2.18% | 315.9K | $10.0M | new | $29.44(+30.33%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +54.80% | +270.92% |
| Top 20 Holdings Unweighted | +38.29% | +164.45% |
Sign up free to track Foresite Capital Management VI LLC, compare funds side by side, and get alerts the moment positions change.